Company Active LTD

Company profile

Spheritech Limited

About Us - Spheritech

Spheritech Limited is a UK company with status active founded in 2009 based in North West England.

CRN
06885285
Founded
2009
Age
17

Overview

Legal name
SPHERITECH LIMITED
Region
North West England
Registered address
SPHERITECH LTD
THE HEATH BUSINESS & TECHNICAL PARK
RUNCORN
CHESHIRE
WA7 4QX
Insolvency history
No

Latest accounts

Financial period: 1 Jul 2024 to 30 Jun 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
4

Company events

Reference milestones and recent Companies House filing stream events.

7 events
31 Mar
2027

Accounts due

Accounts Due

Next accounts due date

22 Oct
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

08 Oct
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Jun
2025

Accounts filed

Accounts

Last accounts made up date

08 Oct
2024

Change To A Person With Significant Control

Persons-with-significant-control

PSC04 | Transaction MzQzODczMjc0OWFkaXF6a2N4

Published 08 Oct 2024 12:39

08 Oct
2024

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQzODczMjY3NWFkaXF6a2N4

Published 08 Oct 2024 12:38

23 Apr
2009

Incorporated

Inception

Company registered at Companies House

Public funding

5 awards
First funded
2010
Funded years
2010, 2014, 2017, 2020
Age at first award
0 years

Projects

2020 Feasibility Studies Lead participant

A Novel Antiviral Filter for Face Masks

1 Jun 2020 to 31 Mar 2021

Awarded
£56,020
Total cost £56,020

Face masks currently in use by healthcare professionals in the NHS and in social care were not designed to be specifically antiviral. Even worse, the simple cloth and paper disposable masks often used by the general public offer little protection and may even be reservoirs to catch and retain droplets containing viruses. In these unprecedented times when ...

2017 Feasibility Studies Lead participant

SpheriSome® Hb

1 Aug 2017 to 31 Jul 2018

Awarded
£69,781
Total cost £99,687

Blood substitutes are of immense importance in circumstances where immediate blood supply is required but cannot be supplied through traditional blood transfusion (e.g. in trauma units, haemophilia, cases where blood can be contaminated by disease, during transplant surgery, or on the battlefield). This project will explore the technical feasibility of de...

2017 Collaborative R&D

ADROIT – Arthroscopically-Deliverable Regenerative Osteochondral Implant Technology

1 Jan 2017 to 31 Dec 2018

Awarded
£173,554
Total cost £247,934

Osteoarthritis (OA) the disease that this project targets, imposes massive burden on society not only in terms of loss of quality of life for the individual, but also in terms of costs – directly to the Health Services for their treatment and indirectly from loss of earnings and impact on their carers: and it is getting worse. Despite this, treatment is o...

2014 Launchpad Lead participant

Proliferate - wound care

1 Feb 2014 to 31 Jan 2016

Awarded
£100,000
Total cost £194,589

Both chronic and burns wounds are instantly recognised by the continuous leaching of exudate from the wound. The key purpose of a dressing for these wounds is the removal of this aqueous seepage and moisture retention by covering with a hydrophilic adsorbent material. Collagen based dressings have proved beneficial in these applications because they encou...

2010 Legacy RDA Grant for R&D Lead participant

A Novel Inexpensive Process for Preparation of Polymeric Microspheres

1 Apr 2010 to 31 Mar 2012

Awarded
£99,753
Total cost £166,756

The technology patented by SpheriTech and described in this application is not only novel but provides an inexpensive and efficient means for manufacture of polymeric microspheres. Page 3 of44 The most important objective is to identify a range of polymers and linkage technologies for the three target markets. Identification of specific protocols and tech...

Product types

Collaborative R&D Feasibility Studies Launchpad Legacy RDA Grant for R&D